Menu
A

Austin Regional Clinic | ARC Far West Medical Tower

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Apremilast
Guselkumab
Methotrexate
DX-2930
Adalimumab
BMS-986165
Ixekizumab
Tocilizumab
Tofacitinib
Ustekinumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

The purpose of this study was to assess efficacy, including inhibition of radiographic progression, and safety with upadacitinib versus placebo and v...

Active, not recruiting
Rheumatoid Arthritis
Drug: Placebo for Upadacitinib
Drug: Upadacitinib

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) axial disease by...

Enrolling
Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the...

Active, not recruiting
Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Enrolling
Systemic Lupus Erythematosus
Drug: Deucravacitinib
Other: Placebo

The RESET-RA study will assess the safety and efficacy of the SetPoint System (study device) for the treatment of adult patients with active, moderat...

Active, not recruiting
Rheumatoid Arthritis
Procedure: Implant Procedure
Device: Non-active stimulation
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trial sponsors

Amgen logo
Janssen (J&J Innovative Medicine) logo
The University of Texas System (UT) logo
Exact Sciences Corporation logo
Pfizer logo
Celgene logo
G
Shire logo
AbbVie logo
Boehringer Ingelheim logo